iToBoS project has been selected to participate in the EU Innovation Radar.
The Innovation Radar is a European Commission initiative to identify and collect structured data about the innovation profile of EU funded projects and their outputs. Its goal is to identify high-potential innovators and innovations; their specific ‘go to market’ needs and provide targeted recommendations. The aim is ultimately to encourage and support innovators in getting their innovations 'out of the lab' and into (or at least closer to) the market.
iToBoS (Intelligent Total Body Scanner for Early Detection of Melanoma) contributed with more than 20 innovative assets. The project aims at developing an AI diagnostic platform for early detection of melanoma. The platform includes a novel total body scanner and a Computer Aided Diagnostics (CAD) tool to integrate various data sources such as medical records, genomics data and in vivo imaging.
The developments within the project will lead to a precision diagnostic system that will incorporate classical demographic data (age, sex), clinical phenotype (anatomical location of every lesion and skin phototype), genotype (mutations in hereditary melanoma genes and genetic variations in melanoma susceptibility genes) and an imaging phenotype (including number and size of naevi, degree and area of photo-damaged skin, as well as clinical dermoscopic image characteristics of the lesions, acquired by the total-body high-resolution scanner). The combination of all this personalised information will result in an accurate, detailed and structured assessment of the pigmented skin lesions of the patient.